Revenue | ₹5.51Cr |
Net Profits | ₹-2.48Cr |
Net Profit Margins | -45.01% |
Pharmaids Pharmaceuticals Ltd’s revenue jumped 16.74% since last year same period to ₹5.51Cr in the Q3 2025-2026. On a quarterly growth basis, Pharmaids Pharmaceuticals Ltd has generated -52.62% fall in its revenue since last 3-months.
Pharmaids Pharmaceuticals Ltd’s net profit fell -28.5% since last year same period to ₹-2.48Cr in the Q3 2025-2026. On a quarterly growth basis, Pharmaids Pharmaceuticals Ltd has generated 1.59% jump in its net profits since last 3-months.
Pharmaids Pharmaceuticals Ltd’s net profit margin fell -10.07% since last year same period to -45.01% in the Q3 2025-2026. On a quarterly growth basis, Pharmaids Pharmaceuticals Ltd has generated -107.72% fall in its net profit margins since last 3-months.
The revenue for Pharmaids Pharmaceuticals Ltd in the Q3 results 2025 was ₹5.51Cr.
The net profit for Pharmaids Pharmaceuticals Ltd in the Q3 results 2025 was ₹-2.48Cr.
The net profit margin for Pharmaids Pharmaceuticals Ltd in the Q3 results 2025 was -45.01%.
The revenue for Pharmaids Pharmaceuticals Ltd in the Q3 results 2024 was ₹4.72Cr.
The net profit for Pharmaids Pharmaceuticals Ltd in the Q3 results 2024 was ₹-1.93Cr.
The net profit margin for Pharmaids Pharmaceuticals Ltd in the Q3 results 2024 was -40.89%.